Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) Research & Development (2024 - 2026)

Nexalin Technology has reported Research & Development over the past 2 years, most recently at $224940.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 69.49% year-over-year to $224940.0; the TTM value through Dec 2025 reached $1.1 million, down 9.02%, while the annual FY2025 figure was $1.1 million, 9.02% down from the prior year.
  • Research & Development for Q4 2025 was $224940.0 at Nexalin Technology, down from $226520.0 in the prior quarter.
  • Over five years, Research & Development peaked at $737242.0 in Q4 2024 and troughed at $105668.0 in Q1 2024.